Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T01:04:51.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The study record page now renders a 403 Forbidden error, replacing the expected study details with an access-restricted page. This indicates a permissions issue rather than a change to the study data.
    Difference
    17%
    Check dated 2026-09-23T01:09:05.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.6 to v3.7.0, indicating a newer version of the page. This appears to reflect a software/content revision rather than a substantive update to study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-09-16T00:16:21.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New revision tag added: 'Revision: v3.6.6' replacing the previous 'Revision: v3.6.5'. This appears to be a routine platform update and does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-09-01T19:51:06.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small site update. It does not modify the displayed study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-11T21:46:05.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.3 to v3.6.4, signaling a minor technical update rather than any change to study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-21T13:58:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.